Literature DB >> 22553703

Side population cells from HXO-Rb44 retinoblastoma cell line have cancer-initiating property.

Jun-Jun She1, Peng-Ge Zhang, Xiang-Ming Che, Xuan Wang, Zi-Ming Wang.   

Abstract

AIM: To ascertain whether side population (SP) cells in HXO-Rb44 retinoblastoma cell line have cancer stem cell-like property in vitro and in vivo.
METHODS: We analyzed and sorted SP from HXO-Rb44 retinoblastoma cell line by Hoechst 33342 staining on flow cytometry. SP and NSP cells were determined their ability of proliferation and self-renewal by SP reanalysis, soft agar assay and tumor sphere assay in vitro. Clone formation was detected by seeding HXO-Rb44 and HXO-Rb44 -RFP cells into soft agar. The expression of ABCG2, MDRI, Bmi-1 and Oct-4 was determined by RT-PCR between SP and non-SP (NSP) cells. Moreover, they were injected into nude mice to determine their tumorigency in vivo.
RESULTS: SP from HXO-Rb44 retinoblastoma cell line could grow clonally in soft agar assays and form tumor spheres from single cells in conditioned media. The expressions of ABCG2, MDRI, Bmi-1 and Oct-4 were significantly higher in SP than NSP cells. As few as SP cells resulted in tumor formation in 6 of 12 injected sites, however, the injection of NSP cells failed to form new tumor.
CONCLUSION: SP cells isolated by Hoechst 33342 from the HXO-Rb44 retinoblastoma cell line had property of high tumorigency in vivo and in vitro. Therefore, SP might be a target while developing retinoblastoma therapies.

Entities:  

Keywords:  HXO-Rb44; retinoblastoma; self-renewal; side population

Year:  2011        PMID: 22553703      PMCID: PMC3340729          DOI: 10.3980/j.issn.2222-3959.2011.05.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  15 in total

1.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase.

Authors:  Oz Pomp; Oliver Dreesen; Denise Fong Mei Leong; Orit Meller-Pomp; Thong Teck Tan; Fan Zhou; Alan Colman
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

Review 3.  Bmi-1, stem cells and cancer.

Authors:  Lili Jiang; Jun Li; Libing Song
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-07       Impact factor: 3.848

4.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

Authors:  H Niwa; J Miyazaki; A G Smith
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.

Authors:  Karthika Natarajan; Yi Xie; Takeo Nakanishi; William T Beck; Kenneth S Bauer; Douglas D Ross
Journal:  Biochim Biophys Acta       Date:  2011-06-28

Review 6.  Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours.

Authors:  C S Parkins; S A Hill; M R Stratford; M F Dennis; D J Chaplin
Journal:  Exp Physiol       Date:  1997-03       Impact factor: 2.969

Review 7.  Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Authors:  L Austin Doyle; Douglas D Ross
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

Review 8.  Epithelial stem cells and malignancy.

Authors:  Daniela E Costea; Luke Gammon; Kayoko Kitajima; Lisa Harper; Ian C Mackenzie
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

Review 10.  Mammary stem cells and breast cancer--role of Notch signalling.

Authors:  Gillian Farnie; Robert B Clarke
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

View more
  2 in total

1.  Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway.

Authors:  Qingfeng Meng; Yan Zhao; LiXin An; Xia Li; Ping Liu
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

2.  Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition.

Authors:  Xiao-Yu Zheng; Lin-Jie Li; Wei Li; Pei-Fang Jiang; Hong-Qiang Shen; Ying-Hu Chen; Xi Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-03       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.